PIK3CA Mutations trials recruiting in New Jersey

Fewer than 3 recruiting trials found.

All PIK3CA Mutations trials nationally

1

Recruiting in New Jersey

1

Cities with sites

Cities in New Jersey

East Brunswick 1

Recruiting trials in New Jersey

A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
NCT07383506 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · New Jersey: East Brunswick

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.